Gainers
- Clearside Biomedical (NASDAQ:CLSD) stock moved upwards by 14.8% to $1.55 during Thursday's after-market session. The company's market cap stands at $92.4 million. As per the press release, Q4 earnings came out today.
- electroCore (NASDAQ:ECOR) shares increased by 8.5% to $0.56. The company's market cap stands at $39.5 million. As per the news, the Q4 earnings report came out today.
- Frequency Therapeutics (NASDAQ:FREQ) shares rose 6.87% to $2.02. The company's market cap stands at $69.8 million.
- Aspira Womens Health (NASDAQ:AWH) stock increased by 6.73% to $1.11. The market value of their outstanding shares is at $124.4 million.
- OncoCyte (NASDAQ:OCX) shares increased by 5.71% to $1.48. The company's market cap stands at $136.5 million. As per the news, the Q4 earnings report came out today.
- Genocea Biosciences (NASDAQ:GNCA) stock increased by 5.11% to $1.23. The market value of their outstanding shares is at $70.6 million. As per the news, the Q4 earnings report came out today.
Losers
- Orphazyme (NASDAQ:ORPH) shares decreased by 12.7% to $1.1 during Thursday's after-market session. At the close, Orphazyme's trading volume reached 328.4K shares. This is 35.5% of its average volume over the last 100 days. The market value of their outstanding shares is at $38.8 million.
- Vaccinex (NASDAQ:VCNX) stock fell 9.76% to $1.11. The company's market cap stands at $43.8 million.
- Hoth Therapeutics (NASDAQ:HOTH) shares declined by 8.11% to $0.73. Hoth Therapeutics's trading volume hit 224.8K shares by close, accounting for 4.4% of its average volume over the last 100 days. The company's market cap stands at $17.5 million.
- Sunshine Biopharma (NASDAQ:SBFM) stock declined by 7.72% to $2.75. This security traded at a volume of 809.1K shares come close, making up 33.2% of its average volume over the last 100 days. The company's market cap stands at $12.3 million.
- Salarius Pharmaceuticals (NASDAQ:SLRX) stock fell 7.6% to $0.46. At the close, Salarius Pharmaceuticals's trading volume reached 189.7K shares. This is 56.5% of its average volume over the last 100 days. The market value of their outstanding shares is at $20.8 million. The company's, Q4 earnings came out today.
- Gelesis Holdings (NYSE:GLS) stock decreased by 6.82% to $3.83. The market value of their outstanding shares is at $276.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
